Senior Associate Scientist - Oncology In Vivo Pharmacology
Merck Healthcare KGaA
Summary
We are seeking a highly motivated scientist for a Senior Associate Scientist position in the Oncology In Vivo Pharmacology group at EMD Serono. The candidate will work in our state-of-the-art EMD Serono Research and Development Institute located in Billerica, MA, and be an integral part of Oncology and Immuno-Oncology drug discovery. The successful candidate will contribute to the creation of innovative medicines investigating novel molecules in development for cancer therapy.
Job description
Your Role
We are seeking a highly motivated scientist for a Senior Associate Scientist position in the Oncology In Vivo Pharmacology group at EMD Serono. The candidate will work in our state-of-the-art EMD Serono Research and Development Institute located in Billerica, MA, and be an integral part of Oncology and Immuno-Oncology drug discovery. The successful candidate will contribute to the creation of innovative medicines investigating novel molecules in development for cancer therapy.
Responsibilities
- Contribute to study design, planning and performing in vivo studies in mice
- Perform routine procedures including dosing animals by various routes (e.g. oral, intravenous, intraperitoneal, etc), measuring tumors by calipers, non-invasive imaging (bioluminescent imaging), monitor animal health, and sample harvest for multiple tissues and blood
- Perform sample processing from multiple tissue sources for downstream analysis and support sample analysis
- Maintenance of mammalian cell culture in 2D (minimum); perform laboratory procedures in cell culture for creation, culturing, and characterization of 3D tumor organoids
- Follow IACUC protocols and standard operating procedures (SOPs); maintain detailed records of experimental protocols and data in electronic laboratory notebook in accordance with company policy
Minimum Qualifications
Bachelors degree in Pharmacology, Animal Science or other Science field with 2+ years of in vivo experience
Preferred Qualifications
- Strong rodent animal handling and hands-on skills, including dosing (IV, SQ, IP and ID), preparation of test compounds, anesthesia, necropsy, blood and tissue collection for PK and PD biomarker analysis and efficacy
- Strong written and oral communication skills, interpersonal skills and ability to effectively work as part of a team
Requirements
- Bachelors degree in Pharmacology, Animal Science or other Science field
- 2+ years of in vivo experience
- Strong rodent animal handling and hands-on skills
- Dosing (IV, SQ, IP and ID)
- Preparation of test compounds
- Anesthesia
- Necropsy
- Blood and tissue collection for PK and PD biomarker analysis
- Strong written and oral communication skills
- Interpersonal skills
- Ability to effectively work as part of a team
Benefits
- Health Insurance
- Paid Time Off
- Retirement Contributions
Company overview
Merck Healthcare KGaA is the healthcare business sector of the Merck Group, a German multinational science and technology company headquartered in Darmstadt. Founded in 1668, Merck is the world's oldest operating pharmaceutical and chemical company. The Healthcare division focuses on developing innovative therapies across multiple therapeutic areas including oncology, neurology & immunology, fertility, and cardiovascular, metabolic, and endocrinological disorders. With approximately 62,557 employees globally, Merck Healthcare operates in more than 65 countries and generated 40% of the Group's sales in 2024. The company's oncology portfolio includes blockbuster products like Erbitux (cetuximab) for colorectal and head and neck cancers, Bavencio (avelumab) for urothelial carcinoma, and Tepmetko (tepotinib) for MET-altered cancers. In neurology, Mavenclad (cladribine) has achieved blockbuster status for treating relapsing multiple sclerosis, while the fertility division has helped bring over 6 million babies into the world through products like Gonal-f. Merck Healthcare combines a strong established business with specialty innovation, delivering a diversified portfolio of therapies to millions of patients worldwide.